Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-12

Clinical Trial Update: Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fluticasone propionate alone to fluticasone propionate/fluticasone/salmeterol in adolescents and adults with persistent asthma; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)
  • Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2017-04-12